The Colombian pharmaceutical industry association, Afidro, claims a draft government circular listing medicines that will be newly subjected to maximum prices could lead to pricing controls being imposed on an ad hoc basis, causing instability for the sector.
A draft of circular 07 of 2018, which was put out for consultation between June 21 and July 12, subjects...







